Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
CCB’s $400 million China health care fund may...
“In 2010, venture capital investment in China life...
According to reports, China will invest $1.7 trillion...
China released its 12th Five-year Plan for Medical...
OriGene Technologies, a US research tool maker, acquired...
Last week, Roche said it would...
Chongqing Huapont Pharma plans to raise $146 million in a...
Joinn Laboratories, a China pre-clinical CRO, is the...
Reckitt Benckiser, a British maker of OTC drugs, acquired...
Eddingpharm, a China drug in-licensing company, acquired...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
